Testing template - virtual with Zoom

February 12, 2021 to February 21, 2021

The clinical management of BCR-ABL1 negative myeloproliferative neoplasms (MPN) is advancing at a rapid pace. This activity covers the diagnosis, assessment of symptoms burden, and treatment of classical MPN such as polycythemia vera, essential thrombocytosis, and myelofibrosis. The discovery of driver mutations (eg. JAK2V617F) and delineation of the genetic basis of MPNs resulted in significant improvements in the management. ‘Update on the diagnosis of and management of myeloproliferative neoplasms’ is a CME-accredited virtual conference that brings together the leading experts in the United States to discuss recent advances in the management of MPN. This meeting will provide an opportunity to hear from the leading experts on recent advances in MPN, some of which will have immediate clinical applications. Furthermore, each session will also discuss novel emerging treatment options for MPN that may be available in the near future.

This virtual conference is intended to propagate new information to augment the knowledge and clinical competence of the cancer care providers in the following areas:

  • Advances in the diagnosis and assessment of symptom burden in MPN 
  • Interferon and other novel treatment options for polycythemia and essential thrombocytosis
  • Current approved JAK inhibitors for myelofibrosis and novel emerging treatment options

Target Audience

  • Oncologists
  • Residents/Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses

Registration fees: 

Registration to this activity is free for healthcare providers who are NOT employees of ACCME defined ineligible companies (An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients). Please proceed to registration and select "non-industry learner" if you are a healthcare provider involved in patient care and are not an employee of an ineligible company.

If you are an employee of an ineligible company, please select "industry representative" and pay the industry registration fee when registering for this course.

 

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review the updated diagnostic criteria and assessment of symptom burden in MPN and integrate into the clinical practice
  • Identify the role of Interferon and other emerging novel treatment options for polycythemia and essential thrombocytosis
  • Describe the currently approved agents and emerging novel targeted therapies for myelofibrosis
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.
Course opens: 
02/12/2021
Course expires: 
02/21/2021
Event starts: 
02/12/2021 - 7:30pm
Event ends: 
02/21/2021 - 11:30am
Cost:
$1.00
All times are listed in Pacific Standard Time (PST)

May 1, 2021

7:30 AM to 8:00 AM PST – Attendance/Registration

8:00 AM to 8:05 AM PST – Introduction 

8:05 AM to 8:25 AM PST – Diagnosis and assessment of symptom burden in MPN

8:25 AM to 8:30 AM PST – Discussion 

8:30 AM to 8:50 AM PST – Interferon and other novel treatment options for polycythemia and essential thrombocytosis

8:50 AM to 9:05 AM PST – Discussion


9:05 AM to 9:20 AM PST – Break 


9:20 AM to 9:40 AM PST – JAKi therapy and emerging novel targeted therapies for Myelofibrosis

9:40 AM to 9:50 AM PST – Discussion

9:50 AM to 10:20 AM PST – Case-Based Discussion of MPN

10:20 AM to 10:25 AM PST – Adjourn

This meeting is held virtually on Zoom. Register for the activity to participate.

Mark Pegram, MD

Professor of Medicine

Stanford University, Palo Alto, CA

Learn more

Siddhartha Yadav, MD

Hematologist/Medical Oncologist

Mayo Clinic, Rochester, MN

Learn more

Fenting Yan, MD, PhD

Hematologist/Medical Oncologist

Swedish Cancer Institute, Seattle, WA

Learn more

Hannah Linden, MD

Professor of Medicine

University of Washington, Seattle, WA

Learn more

Roberto Leon-Ferre, MD

Hematologist/Medical Oncologist

Mayo Clinic, Rochester, MN

Learn more

  

 

 

 

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 2.0 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.


Nursing Contact Hours 

Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.0 Contact Hours.


ABSM Maintenance of Certificate Recognition Statement: 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.

Please support this meeting by visiting our sponsors and exhibitors in the main exhibit breakout room during the exhibit presentations.

Please note that exhibit presentations are promotional materials separate from the accredited activities. These presentations are held in the exhibit breakout room during designated exhibit hours.

We encourage you to visit the main exhibit breakout room and each company's breakout rooms during exhibit and break hours. 

The following Exhibitors will be making exhibit presentations during the exhibit hours:

CompanyReps PresentingLink to Exhibit Materials and Prescribing information
   
   
   
   

 

Price

Cost:
$1.00
Please login or register to take this course.

Registration Fees:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid registrations will be invoiced $350 per participant. 

 

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity via Zoom, and completion of pre & post tests as well as course evaluations.

 

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you are unable to attend the live meeting after enrollment.

Required Hardware/software

This activitywill be held virtually on Zoom. You will need access to internet and a hardware such as a laptop or desktop computer or a mobile device with Zoom application installed.

For best audio-visual experience, please update your Zoom application before joining the meeting.